Product Details

Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection

• MA holder: Boehringer Ingelheim Vetmedica GmbH
• VM number: 04491/3014
• Territory: Northern Ireland
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Public Assessment Report
  • View Post Authorisation Assessment
• Authorised from: 26/05/2016
• Authorisation route: Mutually Recognised
• Active substances:
  • Canine adenovirus
  • Canine distemper virus
  • Canine parainfluenza virus
  • Canine parvovirus
• Target species:
  • Dogs
• Distribution category: POM-V
• Distributors:
  • Boehringer Ingelheim Vetmedica GmbH